Promoter holding
64.27%
PL
Privi Life Sciences Private Limited - Due diligence report
A 360° intelligence report on Privi Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growth…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Privi Life Sciences Private Limited — 360° Intelligence Report
Generated from MCA filings & public records80/100
Trust Score
Low Risk
Privi Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 80/100. Privi Life Sciences Private Limited is an active private limited indian non-government company incorporated in 1990, operating in the Agriculture sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 27 Jul 2026 from the latest processed filings. Privi Life Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Negative operating earnings - debt service depends on external support.
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
Charges position: 3 open (80.00 cr) · 12 satisfied (17.58 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 3 | 48.0 cr |
| Others | 8 | 48.0 cr |
| Central Bank Of India | 1 | 48.0 cr |
| Allahabad Bank | 1 | 48.0 cr |
| Oriantal Bank Of Commerce | 1 | 48.0 cr |
| The Vysya Bank Ltd. | 1 | 48.0 cr |
Compliance Score: 78/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- Delayed payments to MSME suppliers disclosed (17 disclosure(s)).
- 12 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VINAYKUMAR DOPPALAPUDI RAO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJESH HARICHANDRA BUDHRANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJAN SUNDAR RAMAKRISHNAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANOOP PURSHOTAM BABANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2025)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
34 allotment(s) · 18 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Privi Life Sciences (rwanda) Limited | Subsidiary Company | 74.00% |
| Privi Life Sciences Usa Corporation | Subsidiary Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 60 · Distress 75
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Operating for 36+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
3 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 5.51 Lakh.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence78/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment64/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 80.00 cr already registered.
- Compliance record supports lending.
Investor view67/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
07 Dec 2022
Charge created
Hdfc Bank Limited - 30.00 cr
29 Sep 2022
Director ceased
RAJESH HARICHANDRA BUDHRANI
10 May 2022
Securities allotted
30000 Equity Shares - 30.00 Lakh raised
05 Apr 2022
Director appointed
RAJESH HARICHANDRA BUDHRANI (Director)
23 Oct 2021
Securities allotted
205000 Equity Shares - 2.05 cr raised
14 Jun 2021
Charge satisfied
Others
Charge satisfied
Central Bank Of India
07 Jun 2021
Securities allotted
2263440 Equity Shares - 21.05 cr raised
04 May 2021
Charge satisfied
Others
28 Apr 2021
Charge created
Hdfc Bank Limited - 10.00 cr
16 Apr 2021
Charge created
Hdfc Bank Limited - 40.00 cr
10 Mar 2021
Charge satisfied
Others
19 Nov 2020
Securities allotted
9921 Equity Shares - 9.92 Lakh raised
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
12 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 34 security allotment(s) - amounts available in the full report.
8 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Apna Organics Pvt Ltd | U24110MH1993PTC071280 | Mumbai, Maharashtra, India |
| Vedant Dyestuffs Intermediates Private Limited | U24100MH1993PTC073203 | Mumbai, Maharashtra, India |
| Rcp Distilleries (India) Private Limited | U24299UP2021PTC141223 | Ghaziabad, Uttar Pradesh, India |
| Purdrop Biochem Private Limited | U23200GJ2019PTC110154 | Kadi, Gujarat, India |
| Yogesh Dyestuff Products Private Limited | U24100MH1988PTC046559 | Mumbai, Maharashtra, India |
| Myk Laticrete Private Limited | U26990TG2022PTC167773 | Shaikpet, Telangana, India |
| Setco Inks Private Limited | U20221MH2023PTC409421 | Mumbai, Maharashtra, India |
| Anmol Polymers Private Limited | U74899DL1991PTC044225 | Delhi, Delhi, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Privi Life Sciences Private Limited before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Privi Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Privi Life Sciences Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Privi Life Sciences Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Privi Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Privi Life Sciences Private Limited an active company?
Privi Life Sciences Private Limited has MCA status “Active” with a compliance score of 78/100 (Low Risk).
Is Privi Life Sciences Private Limited financially healthy?
Privi Life Sciences Private Limited has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.
Should I do business with Privi Life Sciences Private Limited?
Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Privi Life Sciences Private Limited?
Promoters hold a majority stake - exact percentages are in the full report. 4 active director(s) are on record.
Does Privi Life Sciences Private Limited have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 12 earlier charge(s) stand satisfied.
Is Privi Life Sciences Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 78/100 (Low Risk).
Is it risky to lend to Privi Life Sciences Private Limited?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
